Navigation Links
Shire Presents Positive Efficacy and Safety Data for velaglucerase alfa in Treatment of Naive Patients With Type 1 Gaucher Disease
Date:2/11/2010

CAMBRIDGE, Mass., Feb. 11 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP; Nasdaq: SHPGY), the global specialty biopharmaceutical company, today presented positive results from its first Phase III study (TKT032) evaluating safety and efficacy of velaglucerase alfa, its investigational enzyme replacement therapy for the treatment of Type 1 Gaucher disease. The data were presented in an oral presentation at the Lysosomal Disease Network (LDN) World Symposium in Miami, Florida. Data from a pediatric subgroup of this study and five year follow-up results from a long-term Phase I/II extension study (TKT025 EXT) conducted in adults were also reported and add to the available data on the long-term safety and efficacy of velaglucerase alfa in patients with Type 1 Gaucher disease.

Both studies (TKT032 and TKT025 EXT) met their primary end-points.

Additionally, Shire reported important findings from a study that compared patient antibody response to velaglucerase alfa and imiglucerase. All patients enrolled in the velaglucerase alfa Phase III clinical studies underwent a comprehensive panel of tests that were developed and validated to assess antibody response. In each study, samples were first screened using an electrochemiluminescence (ECL) assay. Positive samples were confirmed using a quantitative radioimmunoprecipitation (RIP) assay. Positive cut-points were established for the ECL assay as 5 ng/mL as well as in terms of fixed raw counts, and for the RIP assay as 4 ng/mL. The results suggest significant antigenic differences between velaglucerase alfa and imiglucerase, with only 1% seroconversion rates against velaglucerase alfa.

"The combined data presented today provides additional and compelling support f
'/>"/>

SOURCE Shire plc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Shire Submits Biologics License Application (BLA) for REPLAGAL(R) With the U.S. Food and Drug Administration (FDA)
2. Shire Expands its Award-Winning ADHD Support Resource, ADHDSupport.com, by Launching an ADHD Twitter(TM) Page
3. Shire and Teva Settle Litigation Concerning Supply of ADDERALL XR Authorized Generic
4. Shire Announces Publication of Open-Label Study on Coadministration of INTUNIV(TM) (guanfacine) Extended-Release Tablets with Stimulants
5. Shire Re-Launches FOCUS, an Online, Personalized Patient Support Program for Adults with ADHD Taking Vyvanse(R) (lisdexamfetamine dimesylate) Capsules CII
6. Shire Reports Tolerability and Clinical Effects Results of Daytrana(R) (methylphenidate transdermal system) from Study in Adolescents with ADHD
7. Shire Continues to Deliver Excellent Growth From Core Products
8. Shire to Present Important Study Findings on its ADHD Treatments at a Major Psychiatric Meeting on October 29 and 30
9. Shire Presents Results of Five Lialda(R) (mesalamine) Analyses at ACG 2009 Annual Scientific Meeting
10. Shire Targets Fourth Quarter Filing of BLA for REPLAGAL(R) for Fabry Disease With U.S. FDA
11. Shire and Sandoz Settle all Pending Litigation Concerning ADDERALL XR(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2015)... , April 19, 2015  Blueprint Medicines today ... candidate BLU-285 has significant anti-tumor activity in treatment-resistant ... and maintained complete tumor regression in all mice ... were presented at the American Association for Cancer ... advances in treating GIST, there are still subsets ...
(Date:4/17/2015)... /CNW/ - The issue: In ... one lot (lot 710535) of Clavulin-400 (70mL) after receiving a ... found in one bottle of the  product. No other lots ... Clavulin-400 is an oral antibiotic used in adults and ... infections. Clavulin-400 comes as a powder in bottles and is ...
(Date:4/17/2015)... Contego Medical, the first and only ... for angioplasty balloon and stent delivery catheters, announces ... financing round led by Hatteras Venture Partners, an ... medical devices, biopharmaceuticals, diagnostics and related opportunities in ... Partners, Lookout Capital and Medical Mutual. ...
Breaking Medicine Technology:Blueprint Medicines Presents New Preclinical Data Demonstrating Significant Anti-Tumor Activity of BLU-285 in Treatment-Resistant GIST and on Novel Cancer Drug Targets 2Blueprint Medicines Presents New Preclinical Data Demonstrating Significant Anti-Tumor Activity of BLU-285 in Treatment-Resistant GIST and on Novel Cancer Drug Targets 3Blueprint Medicines Presents New Preclinical Data Demonstrating Significant Anti-Tumor Activity of BLU-285 in Treatment-Resistant GIST and on Novel Cancer Drug Targets 4Advisory - Clavulin-400 liquid oral antibiotic: One lot recalled after glass pieces found in one bottle 2Contego Medical Closes $5.6 Million in Series B Funding 2Contego Medical Closes $5.6 Million in Series B Funding 3
... ANGELES, March 3, 2011 InstaCare Corp. (OTC Bulletin ... prescription drugs, home testing products for the chronically ill, ... programs, and a leading developer of revolutionary patent pending ... today announced that it has migrated its recently patent ...
... Virtual Radiologic (vRad), a technology-enabled national ... Central Illinois-based radiology practice serving Champaign/Urbana, Effingham, ... of a strategic alliance, merging Lakeland with ... practice will be called Lakeland Radiology Alliance, ...
Cached Medicine Technology:InstaCare Extends MD@Hand & MD@Work Mobile EMR/EHR Technology to Smart Pad Systems 2InstaCare Extends MD@Hand & MD@Work Mobile EMR/EHR Technology to Smart Pad Systems 3Virtual Radiologic and Lakeland Radiologists Partner to Create Lakeland Radiology Alliance 2Virtual Radiologic and Lakeland Radiologists Partner to Create Lakeland Radiology Alliance 3
(Date:4/19/2015)... has released a new blog post explaining what motorcycles ... plan . , Motorcycles can be difficult to ... auto insurance plans. Insurance brokers have gathered a list ... cheaper to insure. , The budget that a ... auto insurance plan that he/she will buy. When comparing ...
(Date:4/19/2015)... has released a new blog post explaining that ... family members. , Accidental death and dismemberment insurance ... in an accident. The policy will cover car accidents ... plan. However, AD&D insurance can also be an independent ... The newly blog post presents the advantages of owning ...
(Date:4/19/2015)... Fla. (PRWEB) April 19, 2015 The ... DO, MPH, MHCM, FACS, as the inaugural winner of ... at its annual meeting, April 18, in Las Vegas, ... Medical Group, vice chairman of the department of surgery ... and Medical Center in Hartford, Connecticut, was instrumental in ...
(Date:4/19/2015)... April 19, 2015 Broccoli sprout extract ... in a small group of healthy human volunteers, the ... with UPMC CancerCenter , announced today at the ... Meeting in Philadelphia. , The promising results will ... will recruit participants at high risk for head and ...
(Date:4/19/2015)... Carinsurancehints.com has released a new blog post providing a ... insurance benefits . , Drivers who were involved in ... information for claiming auto insurance benefits. Exchanging insurance information is ... most of the damages. The newly released blog post explains ... , Drivers can compare online rates and find the best ...
Breaking Medicine News(10 mins):Health News:Buying Auto Insurance for Motorcycles - Models That Are Cheap to Cover! 2Health News:Accidental Death and Dismemberment Insurance Can Provide Financial Security! 2Health News:Dr. Scott Ellner named inaugural Roger Schenke Award winner 2Health News:Dr. Scott Ellner named inaugural Roger Schenke Award winner 3Health News:Preventing Cancer with Broccoli Sprout Extract 2Health News:Preventing Cancer with Broccoli Sprout Extract 3Health News:An Online Guide About Claiming Auto Insurance Benefits After an Accident 2
... properties of bacteria to form barrier against illness , , ... Polytechnic Institute say that have solved the mystery of ... study, published in the current issue of Colloids ... the thermodynamic properties of bacteria in the urinary tract ...
... National Institutes of Health has awarded $128 million to ... Jeffrey Krischer, PhD, to coordinate worldwide studies on the ... a seven-year award, supports Dr. Krischer,s coordination of the ... , The award adds to the $169 million received ...
... Masimo provides Aurora with technology and sensor standardization ... its facilities - creating efficiencies and cost savings, ... inventor,of Pulse CO-Oximetry and Measure-Through-Motion-and-Low-Perfusion Pulse,Oximetry, announced that ... Masimo SET pulse oximetry technology. The integrated health,care ...
... As tens of thousands of Americans,prepare to attend the ... injury or illness -- and how to deal with ... adequate, appropriate medical care in foreign lands can be,daunting, ... themselves,peace of mind," said Angelo Masciantonio, CEO and co-founder ...
... 31 /Xinhua-PRNewswire/ -- Chindex International,Inc. (Nasdaq: CHDX ... products and services in the People,s Republic of ... fiscal 2009 first quarter,financial results on Thursday, August ... a conference call at 8:00 am ET that ...
... Feat could one day lead to tailor-made cells to treat ... -- Scientists have turned skin cells from patients with Lou ... the patients, own neurons. , An unlimited number of these ... a capability which should result in a better understanding of ...
Cached Medicine News:Health News:Study Explains How Cranberries Prevent Urinary Infections 2Health News:University of South Florida receives new multimillion award to assess juvenile diabetes treatments 2Health News:University of South Florida receives new multimillion award to assess juvenile diabetes treatments 3Health News:Aurora Health Care Completes System-Wide Conversion to Masimo SET Pulse Oximetry Technology 2Health News:Aurora Health Care Completes System-Wide Conversion to Masimo SET Pulse Oximetry Technology 3Health News:Aurora Health Care Completes System-Wide Conversion to Masimo SET Pulse Oximetry Technology 4Health News:Aurora Health Care Completes System-Wide Conversion to Masimo SET Pulse Oximetry Technology 5Health News:Americans Attending Beijing Olympics Should Plan Ahead for Medical Emergencies 2Health News:Chindex International to Report Fiscal 2009 First Quarter Financial Results 2Health News:Chindex International to Report Fiscal 2009 First Quarter Financial Results 3Health News:Scientists Turn Skin Cells Into Motor Neurons in ALS Patients 2Health News:Scientists Turn Skin Cells Into Motor Neurons in ALS Patients 3
Inquire...
The Spex SkinSkan is the only in-vivo, fibre-optic spectrofluorometer designed specifically for skin-fluorescence measurements. It is also ideal for many remote sensing steady-state fluorescence appl...
The unique RF-1501 optical design provides exceptional sensitivity in an incredibly compact instrument....
... of DNA, RNA, Or Fluorescent Tags. Accurate quantitation ... critical to life science research. The RF-Mini 150 ... quantities as small as 1ng/ml of DNA specific ... excitation and emission filters, the RF-Mini 150 can ...
Medicine Products: